jhh103

Jay H. Herman, MD

Contact Dr. Herman

111 South 11th Street
Gibbon Building, Room 8220
Philadelphia, PA 19107

(215) 955-8244
(215) 923-9387 fax

Most Recent Peer-reviewed Publications

  1. RhIG for the treatment of immune thrombocytopenia: Consensus and controversy (CME)
  2. In Reply
  3. Prevention of D sensitization after mismatched transfusion of blood components: Toward optimal use of RhIG
  4. Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity
  5. Lack of effect of donor-recipient Rh mismatch on outcomes after allogeneic hematopoietic stem cell transplantation
  6. Lack of effect of donor-recipient ABO mismatching on outcome following allogeneic hematopoietic stem cell transplantation
  7. Alternative explanation for "muddy plasma" [3]
  8. Acute hypertensive transfusion reactions
  9. Early-onset heparin-induced thrombocytopenia after a 165-day heparin-free interval: Case report and review of the literature
  10. Apheresis platelet transfusions: Does ABO matter?
  11. Platelet dosing
  12. Single-donor platelets reduce the risk of septic platelet transfusion reactions.
  13. Severe cutaneous ulceration following treatment with thalidomide for GVHD
  14. Early prediction of poor hematopoietic progenitor cell (HPC) mobilization
  15. Economic consequences of alterations in platelet transfusion dose: Analysis of a prospective, randomized, double-blind trial
  16. Clinical consequences of alterations in platelet transfusion dose: A prospective, randomized, double-blind trial
  17. Considerations in the selection of a platelet component: Apheresis versus whole blood-derived
  18. Metabolic consequences in very low birth weight infants transfused with older AS-1-preserved erythrocytes
  19. Plateletpheresis in 90- to 110-pound donors using the CS-3000 blood cell separator
  20. Platelet transfusion: A review of key concepts